LBT Innovations Limited (LBT.AX)
AUD 0.02
(N/A%)
AUD 0.02
(N/A%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 | -3.74 Million AUD | 83.4% |
| 2023 | -22.52 Million AUD | -239.17% |
| 2022 | -6.64 Million AUD | 8.53% |
| 2021 | -7.26 Million AUD | -28.81% |
| 2020 | -5.63 Million AUD | -29.56% |
| 2019 | -4.35 Million AUD | -62.01% |
| 2018 | -2.68 Million AUD | 47.69% |
| 2017 | -5.13 Million AUD | -243.5% |
| 2016 | 3.57 Million AUD | 1014.33% |
| 2015 | 321 Thousand AUD | 9.93% |
| 2014 | 292 Thousand AUD | -45.01% |
| 2013 | 531 Thousand AUD | 145.93% |
| 2012 | -1.15 Million AUD | 0.52% |
| 2011 | -1.16 Million AUD | -178.09% |
| 2010 | 1.48 Million AUD | 341.54% |
| 2009 | 337 Thousand AUD | -53.32% |
| 2008 | 722 Thousand AUD | -25.21% |
| 2007 | 965.33 Thousand AUD | 0.0% |
| 2005 | - AUD | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q4 | -1.9 Million AUD | 0.0% |
| 2024 FY | -3.74 Million AUD | 83.4% |
| 2024 Q2 | -1.83 Million AUD | 0.0% |
| 2023 Q2 | -2.98 Million AUD | 0.0% |
| 2023 Q4 | -19.54 Million AUD | 0.0% |
| 2023 FY | -22.52 Million AUD | -239.17% |
| 2022 FY | -6.64 Million AUD | 8.53% |
| 2022 Q4 | -2.86 Million AUD | 0.0% |
| 2022 Q2 | -3.77 Million AUD | 0.0% |
| 2021 Q4 | -3.99 Million AUD | 0.0% |
| 2021 FY | -7.26 Million AUD | -28.81% |
| 2021 Q2 | -3.26 Million AUD | 0.0% |
| 2020 Q2 | -3.1 Million AUD | 0.0% |
| 2020 Q4 | -2.53 Million AUD | 0.0% |
| 2020 FY | -5.63 Million AUD | -29.56% |
| 2019 FY | -4.35 Million AUD | -62.01% |
| 2019 Q4 | -2.67 Million AUD | 0.0% |
| 2019 Q2 | -1.67 Million AUD | 0.0% |
| 2018 FY | -2.68 Million AUD | 47.69% |
| 2018 Q4 | -1.63 Million AUD | 0.0% |
| 2018 Q2 | -1.05 Million AUD | 0.0% |
| 2017 Q2 | -184 Thousand AUD | 0.0% |
| 2017 Q4 | -4.94 Million AUD | 0.0% |
| 2017 FY | -5.13 Million AUD | -243.5% |
| 2016 Q2 | 2.94 Million AUD | 0.0% |
| 2016 Q4 | 637 Thousand AUD | 0.0% |
| 2016 FY | 3.57 Million AUD | 1014.33% |
| 2015 Q4 | -190 Thousand AUD | 0.0% |
| 2015 FY | 321 Thousand AUD | 9.93% |
| 2015 Q2 | 511 Thousand AUD | 0.0% |
| 2014 FY | 292 Thousand AUD | -45.01% |
| 2014 Q2 | 772 Thousand AUD | 0.0% |
| 2014 Q4 | -480 Thousand AUD | 0.0% |
| 2013 Q2 | -916 Thousand AUD | 0.0% |
| 2013 FY | 531 Thousand AUD | 145.93% |
| 2013 Q4 | 1.44 Million AUD | 0.0% |
| 2012 Q2 | -289 Thousand AUD | 0.52% |
| 2012 Q3 | -289 Thousand AUD | 0.0% |
| 2012 Q4 | -289 Thousand AUD | 0.0% |
| 2012 FY | -1.15 Million AUD | 0.52% |
| 2012 Q1 | -290.5 Thousand AUD | 0.0% |
| 2011 FY | -1.16 Million AUD | -178.09% |
| 2011 Q2 | -290.5 Thousand AUD | -178.09% |
| 2011 Q1 | 372 Thousand AUD | 0.0% |
| 2011 Q3 | -290.5 Thousand AUD | 0.0% |
| 2011 Q4 | -290.5 Thousand AUD | 0.0% |
| 2010 Q2 | 372 Thousand AUD | 341.54% |
| 2010 FY | 1.48 Million AUD | 341.54% |
| 2010 Q1 | 84.25 Thousand AUD | 0.0% |
| 2010 Q4 | 372 Thousand AUD | 0.0% |
| 2010 Q3 | 372 Thousand AUD | 0.0% |
| 2009 Q4 | 84.25 Thousand AUD | 0.0% |
| 2009 Q3 | 84.25 Thousand AUD | 0.0% |
| 2009 Q1 | 180.5 Thousand AUD | 0.0% |
| 2009 Q2 | 84.25 Thousand AUD | -53.32% |
| 2009 FY | 337 Thousand AUD | -53.32% |
| 2008 Q2 | 180.5 Thousand AUD | -25.21% |
| 2008 Q3 | 180.5 Thousand AUD | 0.0% |
| 2008 FY | 722 Thousand AUD | -25.21% |
| 2008 Q4 | 180.5 Thousand AUD | 0.0% |
| 2008 Q1 | 241.33 Thousand AUD | 0.0% |
| 2007 Q3 | 241.33 Thousand AUD | 0.0% |
| 2007 FY | 965.33 Thousand AUD | 0.0% |
| 2007 Q2 | 241.33 Thousand AUD | 0.0% |
| 2007 Q4 | 241.33 Thousand AUD | 0.0% |
| 2006 Q1 | - AUD | 0.0% |
| 2005 Q3 | - AUD | 0.0% |
| 2005 FY | - AUD | 0.0% |
| 2005 Q2 | - AUD | 0.0% |
| 2005 Q4 | - AUD | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| 4DMedical Limited | -35.97 Million AUD | 89.605% |
| Adherium Limited | -10.22 Million AUD | 63.42% |
| Aroa Biosurgery Limited | -9.74 Million AUD | 61.634% |
| Atomo Diagnostics Limited | -6.84 Million AUD | 45.384% |
| Anteris Technologies Ltd | -67.33 Million AUD | 94.446% |
| Control Bionics Limited | -5.91 Million AUD | 36.758% |
| CardieX Limited | -6.76 Million AUD | 44.718% |
| Compumedics Limited | -338 Thousand AUD | -1006.509% |
| Cochlear Limited | 356.8 Million AUD | 101.048% |
| CleanSpace Holdings Limited | -3.12 Million AUD | -19.598% |
| Cyclopharm Limited | -4.7 Million AUD | 20.439% |
| EMVision Medical Devices Ltd | -2.72 Million AUD | -37.016% |
| Nova Eye Medical Limited | -8.79 Million AUD | 57.452% |
| HeraMED Limited | -6.78 Million AUD | 44.868% |
| Imricor Medical Systems, Inc. | -22.62 Million AUD | 83.47% |
| ImpediMed Limited | -19.79 Million AUD | 81.102% |
| InhaleRx Limited | -1.44 Million AUD | -159.134% |
| Micro-X Limited | -9.76 Million AUD | 61.7% |
| Neurotech International Limited | -5.06 Million AUD | 26.222% |
| OncoSil Medical Limited | -11.91 Million AUD | 68.607% |
| PolyNovo Limited | 5.26 Million AUD | 171.089% |
| Respiri Limited | -7.12 Million AUD | 47.54% |
| SomnoMed Limited | -12.24 Million AUD | 69.449% |
| Universal Biosensors, Inc. | -6.74 Million AUD | 44.523% |
| Uscom Limited | -2.07 Million AUD | -80.263% |
| Visioneering Technologies, Inc. | -5.06 Million AUD | 26.135% |